3-(2-oxo-5-(trifluoromethyl)benzo[d]oxazol-3(2H)-yl)propanoic acid

ID: ALA4093950

Cas Number: 893725-14-9

PubChem CID: 16636975

Max Phase: Preclinical

Molecular Formula: C11H8F3NO4

Molecular Weight: 275.18

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCn1c(=O)oc2ccc(C(F)(F)F)cc21

Standard InChI:  InChI=1S/C11H8F3NO4/c12-11(13,14)6-1-2-8-7(5-6)15(10(18)19-8)4-3-9(16)17/h1-2,5H,3-4H2,(H,16,17)

Standard InChI Key:  UOFLSFDYMYAREA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   32.5005  -20.0211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4994  -20.8407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2074  -21.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2056  -19.6123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9142  -20.0175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9190  -20.8362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6991  -21.0846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1764  -20.4195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6913  -19.7601    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.9936  -20.4147    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.9561  -21.8603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4128  -22.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6699  -23.2465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1266  -23.8570    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.4702  -23.4118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.7913  -21.2487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0839  -20.8396    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.7907  -22.0659    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.0780  -21.6514    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  8 10  2  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
  2 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
M  END

Associated Targets(Human)

KMO Tchem Kynurenine 3-monooxygenase (379 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 275.18Molecular Weight (Monoisotopic): 275.0405AlogP: 2.09#Rotatable Bonds: 3
Polar Surface Area: 72.44Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.61CX Basic pKa: CX LogP: 1.79CX LogD: -1.55
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.93Np Likeness Score: -1.44

References

1. Liddle J, Beaufils B, Binnie M, Bouillot A, Denis AA, Hann MM, Haslam CP, Holmes DS, Hutchinson JP, Kranz M, McBride A, Mirguet O, Mole DJ, Mowat CG, Pal S, Rowland P, Trottet L, Uings IJ, Walker AL, Webster SP..  (2017)  The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis.,  27  (9): [PMID:28336141] [10.1016/j.bmcl.2017.02.078]

Source